Service Hotline:
互联网药品信息服务资格证书：（陕）-非经营性-2023-0143
The National Cancer Center has just released the 2024 National Cancer Report
Recently, with the approval of the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China on JNCC based on the latest data from tumor registration and follow-up monitoring. The results of this release were jointly calculated by the National Cancer Center and the International Agency for Research on Cancer (IARC), and are consistent and synchronized with the GLOBOCAN 2022 data released by IARC in China. The quality and standardization of cancer registration data in China have been further improved, gaining unanimous recognition both domestically and internationally. The updated malignant tumor burden data can provide more objective basic data for cancer prevention and control and the implementation of national health strategies.
2024-11-05
The biggest threat cancer poses happens when it spreads throughout the body. Cancer that has spread to the lining of the abdominal cavity is particularly tricky.Once these advanced cancers have entered that area,they’re notoriously difficult to treat.Surgery alone is rarely successful,and traditional chemotherapy yields limited results
2022-10-19
Based on the secondary analysis of GOG172 and GOG172 trials in the United States gynecological tumor group(GOG),the researchers found that the survival benefits of intraperitoneal chemotherapy
2022-10-18
Breast cancer is a chronic disease that can be controlled and treated without fear
October is breast cancer prevention month,also known as pink ribbon month.The pink ribbon is a recognized symbol of the global campaign to prevent and treat breast cancer.Pink ribbon,an interpretation of breasts
2022-10-18
HIPEC Improves Ovarian Cancer Survival
Women with stage 3 epithelial ovarian cancer could benefit from the addition of hyperthermic intraperitoneal chemotherapy(HIPEC),also known as a hot chemotherapy bath.Study results published in the New England Journal of Medicine showed that HIPEC improved survival rates by 10%
2022-10-18
Mobile
-
TEL： +86 29 82681864
Fax：+86 29 82681864 E-mail：gd029@126.comAdd: Building 1, Huoju Road, East zone of Xi’an High-tech Development District, Xi'an, China
互联网药品信息服务资格证书（陕）-非经营性-2023-0143